West Pharmaceutical Services Total Liabilities 2010-2022 | WST

West Pharmaceutical Services total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • West Pharmaceutical Services total liabilities for the quarter ending September 30, 2022 were $0.846B, a 10.03% decline year-over-year.
  • West Pharmaceutical Services total liabilities for 2021 were $0.978B, a 4.16% increase from 2020.
  • West Pharmaceutical Services total liabilities for 2020 were $0.939B, a 22.27% increase from 2019.
  • West Pharmaceutical Services total liabilities for 2019 were $0.768B, a 31.86% increase from 2018.
West Pharmaceutical Services Annual Total Liabilities
(Millions of US $)
2021 $978
2020 $939
2019 $768
2018 $583
2017 $583
2016 $599
2015 $671
2014 $713
2013 $765
2012 $835
2011 $744
2010 $669
2009 $692
West Pharmaceutical Services Quarterly Total Liabilities
(Millions of US $)
2022-09-30 $846
2022-06-30 $937
2022-03-31 $969
2021-12-31 $978
2021-09-30 $940
2021-06-30 $901
2021-03-31 $911
2020-12-31 $939
2020-09-30 $864
2020-06-30 $786
2020-03-31 $756
2019-12-31 $768
2019-09-30 $686
2019-06-30 $678
2019-03-31 $667
2018-12-31 $583
2018-09-30 $594
2018-06-30 $592
2018-03-31 $564
2017-12-31 $583
2017-09-30 $614
2017-06-30 $601
2017-03-31 $565
2016-12-31 $599
2016-09-30 $593
2016-06-30 $596
2016-03-31 $594
2015-12-31 $671
2015-09-30 $671
2015-06-30 $674
2015-03-31 $655
2014-12-31 $713
2014-09-30 $703
2014-06-30 $732
2014-03-31 $774
2013-12-31 $765
2013-09-30 $828
2013-06-30 $829
2013-03-31 $831
2012-12-31 $835
2012-09-30 $810
2012-06-30 $783
2012-03-31 $763
2011-12-31 $744
2011-09-30 $707
2011-06-30 $719
2011-03-31 $703
2010-12-31 $669
2010-09-30 $668
2010-06-30 $651
2010-03-31 $674
2009-12-31 $692
2009-09-30 $698
2009-06-30 $685
2009-03-31 $653
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.090B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.518B 20.64
McKesson (MCK) United States $54.853B 16.21
AmerisourceBergen (ABC) United States $35.786B 15.79
Laboratory Of America Holdings (LH) United States $21.403B 10.73
Cardinal Health (CAH) United States $21.201B 16.27
Cooper (COO) United States $15.905B 24.89
CONMED (CNMD) United States $2.752B 27.36
Invacare (IVC) United States $0.018B 0.00